loading...| Preferred Name |
Carmustine [Chemical/Ingredient] |
|
| Synonyms |
BCNU |
|
| ID |
http://purl.bioontology.org/ontology/NDFRT/N0000006684 |
|
| altLabel |
BCNU FIVB 1,3-Bis(2-Chloroethyl)-1-Nitrosourea Carmustine N,N'-Bis(2-Chloroethyl)-N-Nitrosourea Urea, N,N'-bis(2-chloroethyl)-N-nitroso- |
|
| cui |
C0007257 |
|
| Ingredient of |
http://purl.bioontology.org/ontology/NDFRT/N0000148463 http://purl.bioontology.org/ontology/NDFRT/N0000146473 |
|
| MESH DEFINITION |
A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) |
|
| MESH DUI |
D002330 |
|
| MeSH name |
Carmustine |
|
| MESH UI |
M0003490 |
|
| NDFRT kind |
INGREDIENT_KIND |
|
| notation |
N0000006684 |
|
| NUI |
N0000006684 |
|
| prefLabel |
Carmustine [Chemical/Ingredient] |
|
| tui |
T109 T121 |
|
| subClassOf |